Understanding the effect of obesity on papillary thyroid cancer: is there a need for tailored diagnostic and therapeutic management?
[INTRODUCTION] Several studies have focused on the relationship between obesity and differentiated thyroid carcinoma (DTC), particularly papillary histotype (PTC).
APA
Matrone A, Basolo A, et al. (2022). Understanding the effect of obesity on papillary thyroid cancer: is there a need for tailored diagnostic and therapeutic management?. Expert review of endocrinology & metabolism, 17(6), 475-484. https://doi.org/10.1080/17446651.2022.2131529
MLA
Matrone A, et al.. "Understanding the effect of obesity on papillary thyroid cancer: is there a need for tailored diagnostic and therapeutic management?." Expert review of endocrinology & metabolism, vol. 17, no. 6, 2022, pp. 475-484.
PMID
36203362
Abstract
[INTRODUCTION] Several studies have focused on the relationship between obesity and differentiated thyroid carcinoma (DTC), particularly papillary histotype (PTC). However, the association of obesity with both incidence and aggressiveness of PTC is still incompletely understood.
[AREAS COVERED] We reviewed the mechanisms underlying the cross talk between obesity and thyroid carcinomas and described the most recent evidence evaluating the effect of obesity on the development of PTC, as well as the impact of excessive body weight on the clinicopathologic features and outcome of this type of cancer.
[EXPERT OPINION] Available evidence suggests that excessive body weight is linked with a higher risk of getting PTC, while its impact on the aggressiveness of the disease, if present, is still not clear. Therefore, while attention should be paid to discover thyroid cancer in patients with obesity earlier, once diagnosed it should be managed following a conventional workup as in normal weight patients, based on the clinical presentation of the disease and including active surveillance if appropriate, as recommended by referral guidelines.
[AREAS COVERED] We reviewed the mechanisms underlying the cross talk between obesity and thyroid carcinomas and described the most recent evidence evaluating the effect of obesity on the development of PTC, as well as the impact of excessive body weight on the clinicopathologic features and outcome of this type of cancer.
[EXPERT OPINION] Available evidence suggests that excessive body weight is linked with a higher risk of getting PTC, while its impact on the aggressiveness of the disease, if present, is still not clear. Therefore, while attention should be paid to discover thyroid cancer in patients with obesity earlier, once diagnosed it should be managed following a conventional workup as in normal weight patients, based on the clinical presentation of the disease and including active surveillance if appropriate, as recommended by referral guidelines.
MeSH Terms
Humans; Thyroid Cancer, Papillary; Carcinoma, Papillary; Thyroid Neoplasms; Obesity; Incidence
같은 제1저자의 인용 많은 논문 (5)
- Fatal tracheal perforation following Dabrafenib-Trametinib therapy in V600E-mutant mixed anaplastic thyroid cancer.
- Timing and Ideal Patient for an Appropriate Search for Somatic Mutation in Medullary Thyroid Cancer.
- Erectile Dysfunction in Patients Treated with Selpercatinib for -Altered Thyroid Cancer.
- Long-Term Outcome of Patients with Low-Risk Differentiated Thyroid Cancer Treated with Total Thyroidectomy Alone.
- BRAF K601E Mutation in Oncocytic Carcinoma of the Thyroid: A Case Report and Literature Review.